PET-B: Post Extraction use of TetraMax Part B (TMB). A comparator controlled clinical investigation comparing the bone healing capability of the investigational product "TetraMax plus BioOss" and the gold standard standard of care comparator "BioOssCollagen" (BioOssCol) for adults who have been treatment planned for tooth extraction/s and implant placement at the same extraction site/s.

Exclusion Criteria10

• Participants <18 years of age.
• Participants with acute infection at the target site or a surgical site located near infection.
• Pregnant or lactating women, or women of childbearing potential who are not willing to avoid becoming pregnant during the study.
• Participants who are concurrently enrolled in another clinical study, or who have or received an investigational device or drug within the past four (4) weeks.
• Participants with a history of a psychological illness or condition such as to interfere with the Participant's ability to understand the requirements of the study.
• Participants unwilling or unlikely, in the Principal Investigator’s opinion, to comply with the study follow-up.
• Participants who are undergoing or are to undergo an immunosuppressive therapy.
• Participants with active cancer.
• Participants who have received radiation therapy to the jaws.
• Participants taking any drugs shown to alter bone metabolism within the jaws (e.g., bisphosphonates).